Exercise and Ectopic Fat Deposition

Overweight Clinical Trial

— ectofat  

Official title:

Effect of Diet Plus Exercise Versus Diet Alone on the Reduction of Ectopic Fat Deposition in Adults With Overweight

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02831621
• Other study ID #: 14/17/205
• Status: Completed
• Phase: N/A
• Start date: June 2016
• Est. completion date: January 2019

Study information

• Verified date: January 2019
• Source: Universiteit Antwerpen
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Excess ectopic fat deposition is associated with development of cardiovascular and metabolic diseases. This study investigates how lifestyle interventions can have an effect on different sites of ectopic fat deposition and cardiovascular or metabolic factors. Moreover, the clinical and economic value of exercise to supplement a hypocaloric diet is investigated.

Endocrinologists of the University Hospital of Antwerp, Belgium, will be recruiting women during consultations. Also, recruitment posters will be used in the University Hospital of Antwerp and the University of Antwerp. Potential participants meeting all a priori set inclusion and exclusion criteria will be randomized by minimization method to a hypocaloric diet group (usual care) or a group of hypocaloric diet combined with physical fitness training. Both groups will undergo an intake procedure in which personal goals are set and barriers to changes in behavior will be discussed. Ectopic fat deposition will be measured by imaging techniques after three and six months of intervention. Based on the known relationship between ectopic fat and cardiovascular outcomes, the short term study results will then be extrapolated to an estimation of the reduction of cardiovascular events.

The following clinical outcomes will be presented: change in ectopic fat in the abdomen (visceral fat), the liver (intra hepatic lipids), skeletal muscle (intra myocellular lipids), heart (epicardial fat) after a dietary or combined (diet+physical activity) intervention. The impact of supervised exercise in addition to diet will be expressed in projected healthcare costs and quality adjusted life years.

Description:

protocol of the study was published, Hens et al. (physioscience 2017; 13: 80-87)

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: January 2019
• Est. primary completion date: August 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Participants should be willing to undergo a weight loss intervention and body weight must be stable during the past six months.

• There will be no upper eligibility criterion for body mass index (BMI) but BMI should be at least 27 kg/m².

Exclusion Criteria:

• Individuals who have a clinical history of type 2 diabetes, prediabetes (with use of medication), or hypothyroidism will be excluded.

• when postmenopausal; Premenopausal state will be verified by hormonal data (follicle-stimulation hormone (FSH) < 25 mU/ml and estradiol > 20 pg/ml).

• Subjects will not be allowed when pregnancy is planned

• when physical activity is not possible due to problems of the musculoskeletal system

• when changes in medication (e.g. beta blockers) are advised by an endocrinologist.

• when smoking

• when drinking more than two alcoholic consumptions/day or binge drinking (self-reported)

• when taking medication that influences body weight or metabolism (e.g. tricyclic antidepressants)

• Since all participants will undergo medical imaging, exclusion criteria related to MRI and CT scans are also applicable.

Related Conditions & MeSH terms

• Overweight

Intervention

Behavioral:
• lifestyle intervention (diet OR diet+exercise)
diet or diet+fitness training

Locations

Country	Name	City	State
Belgium	University Hospital of Antwerp	Antwerp

Sponsors (1)

Lead Sponsor	Collaborator
Universiteit Antwerpen

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	hepatic lipid content	The hepatic lipid content will also be measured by a 3T MRI scanner (SIEMENS MAGNETOM Prisma, Siemens Healthcare AG, Zürich, Germany). The body coil will be positioned around the chest, as the subjects lay supine. MRI data will be acquired using STEAM, with the parameter setting as follows: 3.0 cm³ voxel in the right liver, TR/TE 3000/20 ms, and no water suppression.	start - 3 months - 6 months - 12 months
Primary	intra myocellular lipids	1H-magnetic resonance spectroscopy (1H-MRs) will be used to quantify lipid levels in the tibialis anterior (slow-twitch) muscle of each subject.The right calf of each subject will be positioned near isocenter surrounded by a body coil within a 3T MRI scanner (SIEMENS MAGNETOM Prisma, Siemens Healthcare AG, Zürich, Germany) following manual shimming on the volume of interest to ensure maximum ?eld homogeneity. The 1H-MRs data will be acquired by a single-voxel Point-Resolved Spectroscopy (PRESS) acquisition. Imaging parameters will be set as follows; repetition time (TR)/echotime (TE) 2000/33 ms, voxel size 15 mm³, and weak water suppression.	start - 3 months - 6 months - 12 months
Primary	pericardial and epicardial fat	Multislice ECG-triggered CT will be used to measure pericardial and epicardial fat areas. All scans will be performed at end-diastole and slice thickness of 2.5 mm. No contrast liquid will be used. Data will be analyzed using the corresponding workstation (GE, AW Volumeshare 2).	start - 3 months - 6 months - 12 months
Primary	visceral fat	A single slice CT of the abdomen will be used to evaluate cross-sectional abdominal visceral adipose tissue areas at the L4-L5 region. The abdominal fat mass and its distribution in visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) will be calculated by area measurement on the corresponding CT slice.	start - 3 months - 6 months - 12 months
Primary	antropometric and metabolic parameters	Every participant will undergo a standard metabolic screening at the beginning of the study. This will include a detailed interview and a clinical examination with anthropometry.	start - (some at) 3 months - 6 months - 12 months
Primary	health economic evaluation	questionnaires will be used	start - 3 months - 6 months - 9 months - 12 months